Target intelligence / Profile preview

Human cytomegalovirus virion (CMV virion or HCMV virion)

Target
CMV virion or HCMV virion
Molecular classification
Other (virus particle/virion), Contains: Envelope proteins (e.g., glycoprotein B, gB; glycoprotein H, gH; glycoprotein M, gM), Contains: Tegument proteins (e.g., pp65, pp150), Contains: Capsid proteins (e.g., major capsid protein, MCP), Not a receptor, enzyme, transporter, transcription factor, or ion channel.
01

Overview

Human cytomegalovirus virion is a large, enveloped virus particle, icosahedral in structure, approximately 150–200 nm in diameter, classified as a beta-herpesvirus (human herpesvirus 5). The virion comprises a lipid bilayer envelope studded with glycoproteins that facilitate viral entry and immune evasion, an icosahedral capsid protecting the genome, and a tegument layer loaded with viral and host proteins that modulate cellular responses. The core contains a linear double-stranded DNA genome (~230 kbp). The virion's complex protein composition includes at least 70 viral proteins and over 70 host proteins; prominent viral proteins include envelope glycoprotein B (gB), glycoprotein H (gH), tegument protein pp65 (UL83), pp150 (UL32), and major capsid protein (MCP/pUL86). The virion functions in protection, transmission, and delivery of the viral genome and is central to infection pathogenesis, but only its component molecules are suitable targets for therapeutic intervention. The term "Cytomegalovirus virion" refers generically to the complete physical virus particle and is not a precise molecular target for drug discovery or screening. Drug action is focused on specific components (enzymes, glycoproteins), not the intact virion.

Other names
Human cytomegalovirus virionHCMV virionCMV virionHuman herpesvirus 5 virionHerpesvirus cytomegalovirus virion
02

Mechanism of action

Inhibition of viral DNA polymerase (ganciclovir, valganciclovir, foscarnet, cidofovir) Inhibition of viral terminase complex (letermovir) Inhibition of viral kinase UL97 (maribavir) Drugs act on viral molecular machinery, not directly on the intact virion particle.

03

Biological functions

Infection and transmissionViral entry and cell fusionGenome delivery to the host nucleusImmune evasionOther (as an assembled viral particle, it serves as the mediator of propagation between cells/hosts)
04

Disease associations

Infection (cause of cytomegalovirus disease, especially in immunosuppressed or neonates; congenital infection)Other: Associated with complications in transplant recipients, congenital birth defects, and opportunistic infections in HIV/AIDS
05

Safety considerations

Drug resistance (mutations in viral DNA polymerase, UL97 kinase, and other proteins)Toxicity of antivirals (bone marrow suppression, nephrotoxicity)Teratogenic risk from congenital infectionImmunosuppressed patients are at high risk for severe disease
06

Interacting drugs

Ganciclovir

5 more in the full profile.

07

Biomarkers

CMV DNA in blood or tissues (via PCR)pp65 antigenemia (level of the viral pp65 protein in blood leukocytes)CMV IgM and IgG antibodies (serology for infection status)

Beyond the preview

Go deeper on Human cytomegalovirus virion (CMV virion or HCMV virion).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Human cytomegalovirus virion (CMV virion or HCMV virion).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call